
Report: U.S. drug spending on par with South Africa’s GDP
U.S. prescription drug spending grew at a surprisingly modest pace in 2016, notes a new report by QuintilesIMS Institute, though the market still exceeds the annual GDP of South Africa.
U.S. prescription drug spending grew at a surprisingly modest pace in 2016, notes a new report by QuintilesIMS Institute, though the market still exceeds the annual GDP of South Africa.
The QuintilesIMS Institute has released a timely report on the global market for medicines, forecasting a slowdown in drug price increases but overall growth to a massive $1.5 trillion by 2021.